Adalank vs Semax
Emerging vs Well Studied
compatible Both are Russian nootropic peptides with different mechanisms.
Molecular Data
Adalank Semax
Weight 792.93 Da 813.93 Da
Half-life Not established 0.5-2 hours
Chain 7 amino acids 7 amino acids
Type Modified heptapeptide ACTH(4-10) synthetic analog
Key Benefits
Adalank
01 Potent anxiolytic effects without sedation
02 Enhanced cognitive function
03 Stress resilience
04 Improved mood and emotional stability
05 Neuroprotection via BDNF upregulation
06 No tolerance, dependency, or withdrawal
Semax
01 Rapid brain delivery via intranasal route
02 Rapidly increases BDNF levels
03 Extensive clinical research in Russia
04 Easy self-administration
05 Modulates dopamine and serotonin systems
06 Neuroprotective effects
Dosing Protocols
Adalank
200-500mcg / Once or twice daily
Anxiety Reduction 200-300mcg 1x daily (morning)
Cognitive Enhancement 200-500mcg 1x daily
Stress Management 200-300mcg 2x daily (morning, afternoon)
Initial Trial 100-200mcg 1x daily
Semax
300-600mcg per dose (up to 1000mcg for intensive use) / 1-2x daily (morning recommended for cognitive boost)
Research protocol 500-750mcg 1x daily
Intensive protocol 750-1000mcg 1-2x daily
Side Effects
Adalank
Parent compound has high safety profile in Russian clinical research
Minimal side effects reported
Semax
Mild nasal discomfort (nasal route)
Possible nasal sensation upon administration
Contraindications
Experimental peptide with limited direct human research on N-Acetyl form
Not recommended during pregnancy or breastfeeding
Consult healthcare provider before use with psychiatric medications
Pregnancy or breastfeeding
Known peptide allergies
Do not exceed 4-week continuous use without medical supervision
Research Evidence
Adalank Semax
Status Emerging Well Studied
References 3 studies 4 studies
Latest — 2021
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.